Y. Ishii-Osai

发表

N-propionyl-4-S-cysteaminylphenol induces apoptosis in B16F1 cells and mediates tumor-specific T-cell immune responses in a mouse melanoma model.

H. Honda, K. Wakamatsu, S. Ito, 2012, Journal of dermatological science.

Effects of rhododendrol and its metabolic products on melanocytic cell growth.

K. Wakamatsu, S. Ito, T. Yamashita, 2015, Journal of dermatological science.

Mechanism of putative neo-antigen formation from N-propionyl-4-S-cysteaminylphenol, a tyrosinase substrate, in melanoma models.

H. Honda, K. Wakamatsu, S. Ito, 2012, Biochemical pharmacology.

Infliximab treatment–induced paradoxical psoriasiform reaction in patient with psoriasis vulgaris showing positive lymphocyte transportation test reaction

T. Yamashita, A. Yoneta, Hitomi Takahashi, 2015, JAAD case reports.

A case report of cutaneous polyarteritis nodosa in siblings

H. Tsutsumi, T. Yamashita, T. Hori, 2018, Modern rheumatology.

Clinical and epidemiological analysis in 149 cases of rhododendrol‐induced leukoderma

T. Yamashita, J. Kato, T. Kamiya, 2017, The Journal of dermatology.

Melanoma-Targeted Chemothermotherapy and In Situ Peptide Immunotherapy through HSP Production by Using Melanogenesis Substrate, NPrCAP, and Magnetite Nanoparticles

H. Honda, Takeshi Kobayashi, K. Wakamatsu, 2013, Journal of skin cancer.

Diagnosis of eight groups of xeroderma pigmentosum by genetic complementation using recombinant adenovirus vectors

T. Yamashita, T. Hida, M. Okura, 2016, The Journal of dermatology.

Circulating melanoma cells as a potential biomarker to detect metastasis and evaluate prognosis

K. Wakamatsu, T. Yamashita, A. Yoneta, 2016, The Australasian journal of dermatology.

Mechanism of putative neo-antigen formation from N-propionyl-4-S-cysteaminylphenol, a tyrosinase substrate, in melanoma models.

H. Honda, K. Wakamatsu, S. Ito, 2012, Biochemical pharmacology.